Biogen has made a $5.6 billion deal to acquire Apellis Pharmaceuticals, the companies announced Tuesday.

The deal will allow Biogen to get hold of the kidney disease drug Empaveli and the eye disease therapy Syfovre …

Subscribe for Updates

Copyright 2025 dijee Intelligence Ltd.   dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registration number 16808844